openPR Logo
Press release

Artificial Pancreas Device System (APDS) Market Strategies and Forecasts 2024 Analysis By Global Players Medtronic, Medtrum, Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Bigfoot Biomedical, Insulet Corporation

11-27-2018 03:53 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Global Artificial Pancreas Device System (APDS) Market

Global Artificial Pancreas Device System (APDS) Market

“Global Artificial Pancreas Device System (APDS) Market Report 2024” report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.

Administering insulin on daily basis is cumbersome for type 1 diabetes (T1D) patients in a busy lifestyle. While devices such as insulin pumps, pens, and jet injectors have made living with diabetes less stressful by ridding users of relatively painful insulin delivering devices such as needles and syringes. Juvenile Diabetes Research Foundation (JDRF) is working in collaboration with many industry players such as Medtronic, Inc., Johnson & Johnson, and Tandem Diabetes Care, Inc. to develop innovative insulin and glucose monitoring systems/devices.

Available Exclusive Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/79

Artificial pancreas is the outcome of these collaborations which is also encouraged for use by the FDA. Artificial pancreas device system (APDS) consists of an insulin pump, sensor, transmitter, and a receiver. MiniMed 530G from Medtronic, Inc. was the first artificial pancreas device system (APDS) approved by FDA. This threshold suspend device system enables temporary suspension of insulin delivery when the glucose level is lower than the threshold level. Another system, Medtrum’s P6 Easy Touch Disposable Pump is a semi-closed loop artificial pancreas that is under clinical trials in Europe. Many such systems are under clinical trials and expected to be launched in near future in the global artificial pancreas device system (APDS) market. Developed economies in North America, Europe and Pacific region would be the potential regional opportunities for this novel system in the global artificial pancreas device system (APDS) market.

Market Dynamics:

The artificial pancreas device system (APDS) market growth would be mainly driven by increasing adoption of the highly useful systems the large base of diabetes type 1 patients, further supplemented by ever increasing incidence of type 1 diabetes. According to the World Health Organization (WHO), number of diabetes patients worldwide increased from 108 million in 1980 to 422 million in 2014. According to Juvenile Diabetes Research Foundation (JDRF), there were around 1.5 million type 1 diabetics worldwide in 2015. JDRF funds research in diabetes 1 and the non-profit organization expected the first artificial pancreas to be commercialized in 2017. According to the Center for Disease Control and Prevention (CDC), type 1 diabetes accounts for around 5% of the total diagnosed diabetes cases in adults in the U.S. Developed regions are expected to dominate the artificial pancreas device system (APDS) market size, as these regions are early adopters of disruptive technologies. With the introduction of this technology, market for insulin pens and injectors is expected to be impacted negatively.

The global artificial pancreas device system (APDS) market was valued at US$ 64.0 million in 2015 and is expected to witness a moderate CAGR of 18.6% during the forecast period (2016 – 2024).

Purchase this report online with List of Tables & Figures and in-depth Table of Contents on “Global Artificial Pancreas Device System (APDS) Market Report 2024” @ https://www.coherentmarketinsights.com/insight/buy-now/79

Key players operating in the global Artificial Pancreas Device System (APDS) market:

• Medtronic
• Medtrum
• Tandem Diabetes Care, Inc.
• Johnson & Johnson
• Beta Bionics
• Bigfoot Biomedical
• Insulet Corporation

Market Taxonomy:

This report segments the global artificial pancreas device system (APDS) market on the basis of technology, distribution channel, end user and geography. On the basis of technology, the global artificial pancreas device system (APDS) market is categorized into Treat to Range/Control to Range (TTR/CTR), Treat to Target/ Control to Target (TTR/CTT) and Threshold Suspended Device Systems. On the basis of distribution channel the global artificial pancreas device system (APDS) market is segmented into e-commerce, Standalone Retail Shops and hospitals. End user of the APDS include type 1 and type 2 diabetic patients. For comprehensive understanding of market dynamics, the global artificial pancreas device system (APDS) market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Detailed Segmentation:

Global Artificial Pancreas Device System (APDS) Market, By Technology:
• Threshold Suspended Device Systems
• Treat to Range/Control to Range (TTR/CTR)
• Treat to Target/ Control to Target (TTR/CTT)

Global Artificial Pancreas Device System (APDS) Market, By Distribution Channel:
• E-commerce
• Standalone Retail Shops
• Hospitals

Global Artificial Pancreas Device System (APDS) Market, By End User:
• Type 1 Diabetic Patients
• Type 2 Diabetic Patients

Global Artificial Pancreas Device System (APDS) Market, By Geography:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa

Grab Your Report at an Impressive Discount @ https://www.coherentmarketinsights.com/insight/request-discount/79

This study answers to the below key questions:

1. What will the market size be in 2024 and what will the growth rate be?
2. What are the key market trends?
3. What are the challenges to market growth?
4. Who are the key players in this market?
5. What are the market opportunities and threats faced by the key players?

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Artificial Pancreas Device System (APDS) Market.

Major Points in Table of Contents:

Global Artificial Pancreas Device System (APDS) Market Report 2024

1. Artificial Pancreas Device System (APDS) Product Definition
2. Global Artificial Pancreas Device System (APDS) Market Manufacturer Share and Market Overview
3. Manufacturer Artificial Pancreas Device System (APDS) Business Introduction
4. Global Artificial Pancreas Device System (APDS) Segmentation (Region Level)
5. Global Artificial Pancreas Device System (APDS) Market Segmentation (Product Type Level)
6. Global Artificial Pancreas Device System (APDS) Market Segmentation (Industry Level)
7. Global Artificial Pancreas Device System (APDS) Market Segmentation (Channel Level)
8. Artificial Pancreas Device System (APDS) Market Forecast 2018-2024
9. Artificial Pancreas Device System (APDS) Segmentation Product Type
10. Artificial Pancreas Device System (APDS) Segmentation Industry
11. Artificial Pancreas Device System (APDS) Cost of Production Analysis
12. Conclusion

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Pancreas Device System (APDS) Market Strategies and Forecasts 2024 Analysis By Global Players Medtronic, Medtrum, Tandem Diabetes Care, Inc., Johnson & Johnson, Beta Bionics, Bigfoot Biomedical, Insulet Corporation here

News-ID: 1402673 • Views:

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 Period till 2027 | Medtronic Plc, Hill-Rom Holdings, iRhythm Technologies
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast Period 2017 - 2025 And The Top Competitors Are Crown Bioscience, ProSpec Tany TechnoGene, BPS Bioscience, Sigma Aldrich Company, Novoprotein Scientific
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca, Novartis AG, and Merck & Co
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases


More Releases for APDS

Silicon Avalanche Photodiodes (Si-APDs) Market: Growth & Covid 19 Impact Analysi …
Silicon Avalanche Photodiodes (Si-APDs) Market Insights 2022 to 2030 Silicon Avalanche Photodiodes (Si-APDs) Market report provides a detailed study of important aspects such as market drivers, restraints, prospects, opportunities, market risks, current trends, and technical and industrial advancements. The report provides comprehensive analysis reports and competitive analysis reports. It provides a thorough study report that includes detailed information of Silicon Avalanche Photodiodes (Si-APDs) market size, market growth, and new players in
Artificial Pancreas Device System (APDS) Market Growth, Trends, Industry Analysi …
The global artificial pancreas device systems market accounted for US$ 481.8 Mn in 2017 and is expected to grow at a CAGR of 20% during the forecast period 2021 - 2027, to account for US$ 2,168.1Mn by 2027. The artificial pancreas device system consists of two types of devices for monitoring diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose meter used to calibrate the
Global InGaAs Avalanche Photodiodes (InGaAs-APDs) Market Huge Growth Opportunity …
LP INFORMATION recently released a research report on the InGaAs Avalanche Photodiodes (InGaAs-APDs) market analysis, which studies the InGaAs Avalanche Photodiodes (InGaAs-APDs)'s industry coverage, current market competitive status, and market outlook and forecast by 2025. Global "InGaAs Avalanche Photodiodes (InGaAs-APDs) Market 2020-2025" Research Report categorizes the global InGaAs Avalanche Photodiodes (InGaAs-APDs) market by key players, product type, applications and regions,etc. The report also covers the latest
Global Artificial Pancreas Device System Market | APDS Industry Report Forecasts …
Global Artificial Pancreas Market Analysis By Type CTR (control to range) and CTT (control to target); By End User (hospitals, medical centers, and others); by Geography (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) to 2025. The report provides forecast and analysis of the global artificial pancreas market. It provides market overview of global artificial pancreas Market of in terms of revenue (in US$ Mn). Furthermore, the
Artificial Pancreas Device System (APDS) Market - Global Industry Insights, Tren …
Administering insulin on daily basis is cumbersome for type 1 diabetes (T1D) patients in a busy lifestyle. While devices such as insulin pumps, pens, and jet injectors have made living with diabetes less stressful by ridding users of relatively painful insulin delivering devices such as needles and syringes. Juvenile Diabetes Research Foundation (JDRF) is working in collaboration with many industry players such as Medtronic, Inc., Johnson & Johnson, and Tandem
Global Artificial Pancreas Device System (APDS) Market Forecast till 2024
Artificial Pancreas Device System (APDS) – Putting the Ease in Diabetes Management Administering insulin on daily basis is cumbersome for type 1 diabetes (T1D) patients in a busy lifestyle. While devices such as insulin pumps, pens, and jet injectors have made living with diabetes less stressful by ridding users of relatively painful insulin delivering devices such as needles and syringes. Juvenile Diabetes Research Foundation (JDRF) is working in collaboration with many